MBAI — Medbright AI Investments Income Statement
0.000.00%
Last trade - 00:00- CA$8.28m
- CA$8.39m
- 14
- 51
- 56
- 35
Annual income statement for Medbright AI Investments, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | 2023 February 28th | R2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.641 | 1.47 | 0.386 | 1.68 | 0.849 |
| Operating Profit | -0.641 | -1.47 | -0.386 | -1.68 | -0.849 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.719 | -1.21 | -0.43 | -11.6 | 0.677 |
| Net Income After Taxes | -0.719 | -1.21 | -0.43 | -11.6 | 0.677 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.719 | -1.21 | -0.43 | -11.6 | 0.677 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.719 | -1.21 | -0.43 | -11.6 | 0.677 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.042 | -0.059 | -0.02 | -0.179 | 0.006 |